financing Metagenomi Raises $175M in Series B Financing Round The company said it will use the new funding to further develop its gene editing tools and advance its therapeutic programs toward the clinic. Freenome Raises $300M in Series D Financing The company will use the funding to support commercialization of its blood-based colorectal cancer detection test and to fuel expansion to other tumor types. Danaher Prices $1B Offering of Senior Notes Net proceeds from the offering are expected to be $984 million, which Danaher plans to use to redeem all outstanding 2.5 percent senior notes due in 2025. Stilla Technologies Raises €31.3M in Financing The firm will use the funds to further expand its global commercial presence and develop a next-generation digital PCR system. Epigenetic Editing Firm Chroma Medicine Launches With $125M in Seed, Series A Financing The Cambridge, Massachusetts-based startup plans to further develop its epigenetic editing platform and advance its pipeline of targeted therapeutics. Nov 16, 2021 Geneoscopy Closes $105M Series B Financing Round Nov 10, 2021 AnPac Bio Prices Public Offering of American Depositary Shares Nov 10, 2021 Viome Raises $54M to Advance mRNA Platform for Diagnosis, Drug Development Oct 1, 2021 CRISPR Bioinformatics Startup Latch Bio Emerges From Stealth With $5M in Seed Funding Sep 22, 2021 Aviv Scientific Closes $40M Series B Financing Round Sep 16, 2021 NanoCellect Raises $35M to Support Commercial Push for Second-Generation Cell Sorter Sep 13, 2021 CRISPR Startup Raises $15M in Seed Round, Aims to Bring Back Woolly Mammoth Sep 9, 2021 Mammoth Biosciences Raises $195M in Two Financing Rounds, Achieves Unicorn Status Premium Aug 24, 2021 DnaNudge Raises $60M Aug 3, 2021 Gene Editing Analysis Firm SeQure Dx Closes $17.5M Series A Funding Round Jul 28, 2021 Strata Oncology Raises $90M in Series C Financing Jul 22, 2021 Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M Premium Jul 13, 2021 Gene Editing Company Prime Medicine Launches With $315M in Financing Jul 6, 2021 Bio-Me Raises NOK 10M for Microbiome Precision Medicine Jun 29, 2021 Saga Diagnostics Raises $12.5M in Series A2 Financing Jun 3, 2021 Helix Raises $50M in Series C Financing May 26, 2021 Clear Labs Raises $60M in Series C Financing Round May 11, 2021 Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development May 4, 2021 Oxford Nanopore Technologies Raises £195M Apr 22, 2021 Genome Editing Company EdiGene Raises RMB 400M in Series B Plus Financing Round Load More Breaking News Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.